Home › NDC Lookup › RxCUI directory › RxCUI 795735

{56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] — RxCUI 795735

RxNorm drug concept · Brand name pack
RxCUI 795735 Brand name pack · BPCK ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI795735
Official name{56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asChantix Continuing Months Of Therapy 1 MG Pack; Chantix Continuing Month Pack 1 MG 56 Count; Chantix 1 MG Tablet Continuing Months Of Therapy Pack
FDA products mapped4
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Varenicline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The tablets, including Chantix, help you quit smoking. Tyrvaya is a varenicline nasal spray used for dry eye disease. They are different products with different uses.
  • You take them by mouth, starting at a lower dose in the first week and then twice daily. You usually begin about a week before your quit date, and treatment lasts 12 weeks. Food do...
  • Nausea is the most common, and it often eases. Vivid dreams, trouble sleeping, constipation, gas, vomiting and headache can also happen. If nausea is hard to handle, talk to your p...
  • Stop the tablets and call right away if you feel agitated or depressed, have unusual changes in behavior or thinking, or have thoughts of suicide. Also stop and get help for seizur...
📖 Read our full Varenicline guide →

🕸️ Concept Web — How {56 (varenicline 1 MG Oral Tablet [Chantix]) } P... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] RxCUI 795735

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Varenicline 591622
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Chantix 636230
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Varenicline Oral Tablet 636670
    • Varenicline Oral Product 1164567
    • Varenicline Pill 1164568
    • Varenicline Oral Tablet [Chantix] 637187
    • Chantix Oral Product 1167380
    • Chantix Pill 1167381
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Varenicline 1 MG Oral Tablet [Chantix] SBD · 637190
  • Varenicline 1 MG [Chantix] SBDC · 637189
  • Varenicline Oral Tablet [Chantix] SBDF · 637187
  • Chantix Oral Product SBDG · 1167380
  • Chantix Pill SBDG · 1167381
  • Chantix BN · 636230

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 795735 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0468-56 56 TABLET, FILM COATED in 1 BOTTLE (0069-0468-56) CHANTIX Pfizer Laboratories Div Pfizer Inc 2006-05-10
00069-0469-28 56 TABLET, FILM COATED in 1 BLISTER PACK (0069-0469-28) CHANTIX Pfizer Laboratories Div Pfizer Inc 2025-09-22
00069-0469-56 56 TABLET, FILM COATED in 1 BOTTLE (0069-0469-56) CHANTIX Pfizer Laboratories Div Pfizer Inc 2006-05-10
00069-0471-28 1 KIT in 1 BLISTER PACK (0069-0471-28) * 11 TABLET, FILM C... CHANTIX Pfizer Laboratories Div Pfizer Inc 2025-09-22
71205-0381-56 1 BLISTER PACK in 1 CARTON (71205-381-56) / 56 TABLET, FILM... CHANTIX Proficient Rx LP 2020-01-09
Observed labelers: Pfizer Laboratories Div Pfizer Inc (4) · Proficient Rx LP (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.